For­mer Bridge­Bio ex­ec launch­es new an­ti-in­flam­ma­to­ry biotech with $169M, but is mum on what ex­act­ly it's do­ing

Paragon Ther­a­peu­tics, an an­ti­body en­gi­neer­ing com­pa­ny, has spun out its an­ti-in­flam­ma­to­ry an­ti­bod­ies in­to Apogee Ther­a­peu­tics, which launched out of stealth Wednes­day morn­ing with a Se­ries …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER